Sign inGet started

Eastern Capital LTD

Insider CIK 1408408 · CYTK 10% owner · TPIV 10% owner · CYCC 10% owner · IBIO 10% owner · PPHM 10% owner · ASTM 10% owner

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
IBIO iBio, Inc. S Sale2020-08-112020-08-1115,864,436$2.92 $46.32M8,629,693SEC↗
IBIO iBio, Inc. S Sale2020-08-102020-08-117,264,864$3.91 $28.41M24,494,129SEC↗
IBIO iBio, Inc. C Conversion deriv2020-08-072020-08-115,785— $00SEC↗
IBIO iBio, Inc. S Sale2020-08-072020-08-111,355,604$3.83 $5.19M31,758,993SEC↗
IBIO iBio, Inc. C Conversion2020-08-072020-08-1128,925,000$0.20 $5.79M33,114,597SEC↗
IBIO iBio, Inc. S Sale2020-08-062020-08-062,768,137$4.18 $11.57M33,114,597SEC↗
IBIO iBio, Inc. S Sale2020-08-052020-08-06900,000$4.46 $4.01M35,882,734SEC↗
IBIO iBio, Inc. S Sale2020-08-042020-08-06600,000$4.39 $2.63M36,782,734SEC↗
MRKR Marker Therapeutics, Inc. J Other deriv2020-06-162020-06-19416,667— $00SEC↗
MRKR Marker Therapeutics, Inc. X Exercise deriv2020-02-182020-02-20416,667— $00SEC↗
MRKR Marker Therapeutics, Inc. X Exercise2020-02-182020-02-20416,667$1.20 $500.0K4,050,001SEC↗
IBIO iBio, Inc. P Buy2018-07-122018-07-132,200,000$0.90 $1.98M8,457,734SEC↗
IBIO iBio, Inc. P Buy deriv2018-06-262018-06-285,785$1000.00 $5.79M5,785SEC↗
IBIO iBio, Inc. P Buy2018-06-262018-06-281,683,334$0.90 $1.52M6,257,734SEC↗
TPIV TAPIMMUNE INC. P Buy2018-05-142018-05-161,300,000$2.40 $3.12M5,300,002SEC↗
IBIO US iBio, Inc. P Buy2017-11-302017-12-0412,000,000$0.20 $2.40M45,744,000SEC↗
CYCC Cyclacel Pharmaceuticals, P Buy deriv2017-07-192017-07-211— $01SEC↗
CYCC Cyclacel Pharmaceuticals, P Buy2017-07-192017-07-21850,000$2.00 $1.70M2,167,261SEC↗
TPIV TAPIMMUNE INC J Other deriv2016-08-102016-08-125,000,000— $01SEC↗
TPIV TAPIMMUNE INC X Exercise deriv2016-08-102016-08-125,000,000— $00SEC↗
TPIV TAPIMMUNE INC X Exercise2016-08-102016-08-125,000,000$0.50 $2.50M25,000,000SEC↗
TPIV TAPIMMUNE INC J Other2016-08-102016-08-123,000,000— $028,000,000SEC↗
IBIO iBio, Inc. P Buy2016-04-072016-04-116,500,000$0.62 $4.03M33,744,000SEC↗
IBIO iBio, Inc. X Exercise deriv2016-01-252016-01-271,784,000— $00SEC↗
IBIO iBio, Inc. X Exercise2016-01-252016-01-271,784,000$0.53 $945.5K27,244,000SEC↗
IBIO iBio, Inc. P Buy2016-01-252016-01-273,500,000$0.62 $2.17M25,460,000SEC↗
TPIV TAPIMMUNE INC X Exercise deriv2015-09-092015-09-1110,000,000— $00SEC↗
TPIV TAPIMMUNE INC X Exercise2015-09-092015-09-1110,000,000$0.20 $2.00M20,000,000SEC↗
TPIV TAPIMMUNE INC X Exercise deriv2015-06-162015-06-185,000,000— $01SEC↗
TPIV TAPIMMUNE INC X Exercise2015-06-162015-06-185,000,000$0.50 $2.50M10,000,000SEC↗
TPIV TAPIMMUNE INC J Other deriv2015-05-282015-06-015,000,000— $00SEC↗
TPIV TAPIMMUNE INC J Other deriv2015-05-282015-06-015,000,000— $00SEC↗
TPIV TAPIMMUNE INC J Other deriv2015-05-282015-06-0110,000,000— $01SEC↗
TPIV TAPIMMUNE INC J Other deriv2015-05-282015-06-0110,000,000— $01SEC↗
TPIV TAPIMMUNE INC J Other deriv2015-05-282015-06-015,000,000— $01SEC↗
TPIV TAPIMMUNE INC J Other deriv2015-05-282015-06-015,000,000— $00SEC↗
ASTM AASTROM BIOSCIENCES INC O Exercise OTM deriv2014-07-092014-07-11362,500— $00SEC↗
ASTM AASTROM BIOSCIENCES INC O Exercise OTM2014-07-092014-07-11362,500$4.80 $1.74M787,489SEC↗
CYTK CYTOKINETICS INC P Buy2014-02-252014-02-27500,000$8.00 $4.00M2,883,845SEC↗
IBIO iBio, Inc. O Exercise OTM deriv2013-10-152013-10-177,500,000$0.40 $3.00M0SEC↗
IBIO iBio, Inc. J Other deriv2013-10-152013-10-177,500,000— $00SEC↗
IBIO iBio, Inc. J Other deriv2013-10-152013-10-177,500,000— $01SEC↗
IBIO iBio, Inc. O Exercise OTM2013-10-152013-10-177,500,000$0.40 $3.00M21,960,000SEC↗
IBIO iBio, Inc. P Buy deriv2013-04-262013-04-301,784,000— $01,784,000SEC↗
IBIO iBio, Inc. P Buy2013-04-262013-04-304,460,000— $014,460,000SEC↗